Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

165.90
Delayed Data
As of Feb 23
 +8.31 / +5.27%
Today’s Change
84.39
Today|||52-Week Range
174.96
+10.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-742.7M-588.2M-84.0M91.6M
 
 
 
 
 
Depreciation63.3M62.3M61.4M61.4M
 
 
 
 
 
Total Other Cash Flow177.1M243.1M243.8M797.2M
 
 
 
 
 
Funds From Operations-502.1M-279.5M238.2M829.7M
 
 
 
 
 
Funds From/For Other Operating Expenses11.1M86.0M2.1M-15.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-513.2M-365.4M236.1M844.9M
 
 
 
 
 
 
InvestingIncrease In Investments-1.4B-685.0M-629.7M-532.6M
 
 
 
 
 
Decrease In Investments1.6B1.1B779.6M369.2M
 
 
 
 
 
Capital Expenditures-51.2M-45.3M-56.6M-99.4M
 
 
 
 
 
Net Assets From Acquisitions -10.0M-80.0M--0.00
 
 
 
Other Investing - Uses0.000.00-20.0M0.00
 
 
Other Investing - Sources--52.0K0.00436.0K
 
 
 
Net Cash Flow Investing72.3M268.9M73.3M-422.4M
 
 
 
 
 
 
FinancingShort Term Borrowings-------300.0M
 
 
Long Term Borrowings302.3M23.7M83.1M34.7M
 
 
 
 
 
Long Term Debt Reduction-81.7M-20.3M-93.0M-19.3M
 
 
 
 
 
Net Proceeds Stock Sale274.6M185.6M68.2M344.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.00------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing2.2M0.0075.0M12.5M
 
 
 
 
Other Uses - Financing--0.00--4.3M
 
 
Net Cash Flow - Financing497.4M188.9M133.3M68.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-2.2M-2.8M-4.7M5.8M
 
 
 
 
 
 
Net Change In Cash56.5M92.3M442.7M491.0M